Skip to main content
Clinical Trials/NL-OMON54554
NL-OMON54554
Recruiting
Phase 2

Mapping of Sentinel lymph node drainage Using SPECT/CT to tailor highly selective elective nodal irradiation in node-negative neck of patients with head and neck cancer - SUSPECT-2 - SUSPECT-2

Antoni van Leeuwenhoek Ziekenhuis0 sites90 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Enrollment
90
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Antoni van Leeuwenhoek Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosed and histopathologically proven lateralized primary HNSCC,
  • T1\-4N0\-2b without midline involvement, originating at one side of the oral
  • cavity, oropharynx, larynx (except T1 glottic), and hypopharynx, and planned
  • for treatment with primary radiotherapy, chemo\-radiotherapy or
  • immuno\-radiotherapy in curative setting
  • Age \>\= 18 years
  • WHO performance status 0 or 1
  • Signed written informed consent

Exclusion Criteria

  • Distant metastatic spread at the time of inclusion
  • Chemotherapy or surgery (for the present tumor), prior to inclusion
  • Previous radiation treatment in the head and neck region, for any reason
  • Previous neck dissection
  • Recurrent or second primary tumor in the head and neck region
  • Head and neck malignancies arising from skin, lip, nose, sinuses,
  • nasopharynx, salivary glands, thyroid gland or esophagus
  • Pregnancy or no active contraception for pre\-menopausal women
  • Known hypersensitivity to iodine or nanocolloid injection
  • Having any condition (physical, mental, sociological) that interferes with

Outcomes

Primary Outcomes

Not specified

Similar Trials